Research location
Panama City
Panama
Advertisement
Research activity in Panama City
PanamaCureCurrent currently publishes aggregate city-level research activity for this location: 113 trials and 131 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Panama City
113 linked trials · page 1 of 3A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)NCT07371468 · 2026-02-10 · 3 site observations
RECRUITING
OMNI 3.1 Surgical System in Subjects With Primary Open-Angle GlaucomaNCT06991270 · 2026-02-01 · 1 site observation
RECRUITING
Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract SurgeryNCT07036510 · 2025-06-12 · 1 site observation
RECRUITING
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV TreatmentsNCT06337032 · 2024-08-27 · 1 site observation
RECRUITING
Feasibility Clinical Evaluation of the Calibreye SystemNCT05885022 · 2023-05-31 · 1 site observation
RECRUITING
Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its ComorbiditiesNCT05363761 · 2022-04-19 · 2 site observations
RECRUITING
sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term.NCT04766866 · 2021-03-02 · 1 site observation
RECRUITING
A Study of the Helix Surgical System in Primary Open-Angle Glaucoma (POAG) and Cataract (HELIX)NCT06948773 · 2025-05-21 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)NCT06687369 · 2024-12-30 · 3 site observations
ACTIVE_NOT_RECRUITING
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)NCT06472076 · 2024-06-10 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With AsthmaNCT06261957 · 2024-05-31 · 3 site observations
COMPLETED
NIS Study Determining Prevalence of HER2-low in Metastatic Breast Cancer PatientsNCT06131424 · 2024-04-23 · 1 site observation
COMPLETED
Perinatal Outcomes in Patients With Elevated sFlt-1/PlGF RatioNCT06403722 · 2023-11-15 · 1 site observation
COMPLETED
MINIject Implantation Combined With Cataract Surgery in Patients With POAG and CataractNCT05432245 · 2023-01-18 · 1 site observation
ENROLLING_BY_INVITATION
Transorbital Ultrasound of Optic Nerve Sheath Diameter Between Healthy Pregnant Women and Those With Severe Preeclampsia.NCT05594056 · 2022-10-21 · 1 site observation
COMPLETED
Study of the CycloPen Micro-Interventional System and Long-Term Clinical OutcomesNCT05506423 · 2022-08-17 · 1 site observation
ACTIVE_NOT_RECRUITING
American Registry of Ambulatory or Acutely Decompensated Heart FailureNCT05295641 · 2022-04-01 · 1 site observation
COMPLETED
DOuBLED - Doubling Outcomes by Lung Cancer Early DiagnosisNCT05091437 · 2021-12-30 · 1 site observation
COMPLETED
HRR Prevalence in LatAm PROSPECT StudyNCT04962880 · 2021-04-21 · 1 site observation
COMPLETED
Cardionomic STOP-ADHF StudyNCT04814134 · 2021-04-12 · 1 site observation
COMPLETED
MINIject (MINI SO627) in Patients With Open Angle Glaucoma Using Single Operator Delivery ToolNCT04517786 · 2021-01-15 · 1 site observation
UNKNOWN
Motiva Flora Tissue Expander PMCFNCT05447988 · 2020-12-14 · 1 site observation
UNKNOWN
MINIject Global Long-Term Follow-up StudyNCT04524416 · 2020-08-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)NCT04222972 · 2020-07-24 · 1 site observation
TERMINATED
MINIject in Patients With Open Angle Glaucoma Using Single Operator Delivery ToolNCT03996200 · 2019-07-23 · 1 site observation
COMPLETED
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast CancerNCT03674112 · 2018-12-19 · 2 site observations
COMPLETED
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple SclerosisNCT03523858 · 2018-05-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-ANCT03447769 · 2018-03-16 · 1 site observation
TERMINATED
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast CancerNCT03371017 · 2018-01-11 · 1 site observation
COMPLETED
MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive MedicationsNCT03374553 · 2017-11-25 · 1 site observation
COMPLETED
A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)NCT03285763 · 2017-10-25 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)NCT03178552 · 2017-09-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Blood Pressure in Adolescents With PReclampsia and Eclampsia.NCT03360240 · 2017-08-01 · 2 site observations
COMPLETED
Restless Leg Syndrome and Severe PreeclampsiaNCT01538147 · 2017-08-01 · 1 site observation
COMPLETED
MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive MedicationsNCT03193736 · 2017-06-19 · 1 site observation
COMPLETED
Cardiac Output Autonomic Stimulation Therapy for Acute Heart Failure (COAST-AHF)NCT03169803 · 2017-05-19 · 1 site observation
UNKNOWN
Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBCNCT02941926 · 2016-11-30 · 1 site observation
COMPLETED
A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular HypertensionNCT02742649 · 2016-04-30 · 1 site observation
COMPLETED
Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast CancerNCT02594371 · 2015-12-02 · 1 site observation
COMPLETED
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)NCT02425891 · 2015-06-23 · 1 site observation
COMPLETED
Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing RegimenNCT02285114 · 2015-01-20 · 1 site observation
COMPLETED
A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI)NCT02273973 · 2014-11-12 · 1 site observation
COMPLETED
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection FractionNCT02226120 · 2014-10-16 · 2 site observations
COMPLETED
Global Non-interventional Heart Failure Disease RegistryNCT02595814 · 2014-07-23 · 1 site observation
TERMINATED
Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of AsthmaNCT02192736 · 2014-07-01 · 1 site observation
TERMINATED
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μgNCT02091986 · 2014-04-01 · 1 site observation
COMPLETED
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing TherapyNCT02008227 · 2014-03-11 · 1 site observation
COMPLETED
A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast CancerNCT01966471 · 2014-01-31 · 1 site observation
COMPLETED
Feasibility Study of Human Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in Patients With Multiple SclerosisNCT02034188 · 2014-01-01 · 1 site observation
COMPLETED
Umbilical Cord Tissue-derived Mesenchymal Stem Cells for Rheumatoid ArthritisNCT01985464 · 2013-10-01 · 1 site observation
UNKNOWN
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.